Recruiting

Observational Study

Sponsor:

Mathematica Policy Research, Inc.

Code:

NCT05146349

Conditions

Any Injury or Illness Acutely Impacting Work

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Minnesota RETAIN

Study Details

Brief summary:

This study is a randomized control trial (RCT) to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. Collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay at work and return to work will be implemented.

Conditions

Any Injury or Illness Acutely Impacting Work

Study ID

NCT05146349

Start date

Dec 23, 2021

Status verified date

Nov, 2021

Completion date

Feb 28, 2026

Anticipated

Primary completion date

Jun, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Must have been unable to work for no more than 6 months prior enrollment; 80% of participants must be within 3 months of their last day of work
  • 18 years or older
  • Minnesota resident
  • Works in Minnesota
  • Employed or currently in the labor force
  • Meets one of the following:

1. Diagnosis of a work related or personal injury or illness that impacts employment
2. Invasive procedure (e.g., surgery) within the past 12-weeks or anticipated within the next 8-weeks that impacts employment

Exclusion Criteria:

  • Legal representation/litigation at the time of enrollment related to their medical condition.
  • Does not have the capacity to give appropriate informed consent
  • Employed by a RETAIN healthcare recipient or subrecipient with an existing return to work program for employees (i.e. Mayo Clinic employees)
  • Worker's compensation recipients that have a qualified rehabilitation consultant (QRC) or a disability case manager (DCM)

Study Design

Enrollment

3200 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

experimental: RETAIN Programming

The experimental group receives the full set of RETAIN intervention activities.

no intervention: Control

The control group does not receive the full set of RETAIN intervention activities.

Interventions

Minnesota RETAIN

RETAIN projects include a combination of medical provider services, stay-at-work/return-to-work (SAW/RTW) coordination services, and other SAW/RTW services. The evaluation compares the treatment group that is eligible to receive the full set of RETAIN intervention activities and an control group that is not.

Primary outcome measure

  • Share of enrollees employed in the fourth quarter after enrollment [ Time Frame: Measured in the fourth quarter after enrollment ]
  • Enrollee earnings in the fourth quarter after enrollment [ Time Frame: Measured in the fourth quarter after enrollment ]
  • Share of enrollees that applied for SSDI or SSI during the 12 months after enrollment [ Time Frame: Measured in the 12 months after enrollment ]

Central Contacts and Locations

Central contacts

Amaka Osuoha, MPH

734-205-3085aosuoha@mathematica-mpr.com

Catherine Turvey, MPH

734-205-3145cturvey@mathematica-mpr.com

Locations

Mn Retain, Mayo Clinic

Recruiting

Rochester, Minnesota, United States, 55905

Contacts

Samantha Westphal, RN, BSN, PHN, CLMS

507-284-4537retain@mayo.edu

Tammy Green, MBA

507-768-5275green.my@mayo.edu

More Information

Sponsor

Mathematica Policy Research, Inc.

Last update posted

Jan 24, 2022

Last verified

Nov, 2021

Keywords

  • RETAIN
  • Minnesota RETAIN
  • MN RETAIN
  • illness recovery
  • injury recovery
  • out of work help
  • work placement assistance
  • job help
  • work help
  • help keeping my job
  • stay at work
  • return to work

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mathematica Policy Research, Inc. on 2022-01-24.